HUP0102788A2 - Ciklofoszfamid filmtabletták és eljárás az előállításukra - Google Patents
Ciklofoszfamid filmtabletták és eljárás az előállításukraInfo
- Publication number
- HUP0102788A2 HUP0102788A2 HU0102788A HUP0102788A HUP0102788A2 HU P0102788 A2 HUP0102788 A2 HU P0102788A2 HU 0102788 A HU0102788 A HU 0102788A HU P0102788 A HUP0102788 A HU P0102788A HU P0102788 A2 HUP0102788 A2 HU P0102788A2
- Authority
- HU
- Hungary
- Prior art keywords
- cyclophosphamide
- coated tablets
- preparation
- tablet
- fillers
- Prior art date
Links
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004397 cyclophosphamide Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000003826 tablet Substances 0.000 abstract 3
- 239000002706 dry binder Substances 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 2
- 239000007941 film coated tablet Substances 0.000 abstract 2
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000007888 film coating Substances 0.000 abstract 1
- 238000009501 film coating Methods 0.000 abstract 1
- 229960001021 lactose monohydrate Drugs 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány ciklofoszfamidot tartalmazó filmtablettákra,tablettamagokra és az előállításukra alkalmas eljárásra vonatkozik. Afilmtabletta egy tablettamagból, amely ciklofoszfamid hatóanyagot, egyvagy több töltőanyagot, egy vagy több szárazon kötő anyagot, egy vagytöbb folyásszabályozó szert, egy vagy több kenőanyagot tartalmaz, ésegy alkalmas filmbevonatból áll, a tablettamag legalább a töltőanyagokegyikeként laktóz-monohidrátot foglal magában, és szárazon kötőszerként előduzzasztott keményítőt nem tartalmaz. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19826517A DE19826517B4 (de) | 1998-06-15 | 1998-06-15 | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
PCT/EP1999/003920 WO1999065499A1 (de) | 1998-06-15 | 1999-06-08 | Cyclophosphamid filmtabletten |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0102788A2 true HUP0102788A2 (hu) | 2002-03-28 |
HUP0102788A3 HUP0102788A3 (en) | 2002-12-28 |
HU226528B1 HU226528B1 (en) | 2009-03-30 |
Family
ID=7870877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0102788A HU226528B1 (en) | 1998-06-15 | 1999-06-08 | Cyclophosphamide coated tablets |
Country Status (29)
Country | Link |
---|---|
US (1) | US20010046504A1 (hu) |
EP (1) | EP1089739B1 (hu) |
JP (1) | JP4891478B2 (hu) |
KR (1) | KR100679872B1 (hu) |
CN (1) | CN1177590C (hu) |
AR (1) | AR019670A1 (hu) |
AT (1) | ATE310523T1 (hu) |
AU (1) | AU771284B2 (hu) |
BG (1) | BG65253B1 (hu) |
BR (1) | BR9911276A (hu) |
CA (1) | CA2333682C (hu) |
CO (1) | CO5070588A1 (hu) |
CZ (1) | CZ302157B6 (hu) |
DE (3) | DE19826517B4 (hu) |
DK (1) | DK1089739T3 (hu) |
ES (1) | ES2255276T3 (hu) |
HK (1) | HK1037959A1 (hu) |
HU (1) | HU226528B1 (hu) |
IL (2) | IL139944A0 (hu) |
NO (1) | NO325154B1 (hu) |
NZ (1) | NZ508888A (hu) |
PL (1) | PL193398B1 (hu) |
RU (1) | RU2236231C2 (hu) |
SK (1) | SK286185B6 (hu) |
TR (1) | TR200003702T2 (hu) |
TW (1) | TWI242450B (hu) |
UA (1) | UA75566C2 (hu) |
WO (1) | WO1999065499A1 (hu) |
ZA (1) | ZA200006998B (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT500063A1 (de) | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
ATE536173T1 (de) | 2002-02-21 | 2011-12-15 | Biovail Lab Int Srl | Formulierungen mit modifizierter freisetzung von mindestens einer form von tramadol |
DE102005008797A1 (de) * | 2005-02-25 | 2006-09-07 | Baxter International Inc., Deerfield | Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
JO3659B1 (ar) * | 2010-06-02 | 2020-08-27 | Astellas Deutschland Gmbh | أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية |
UA112170C2 (uk) | 2010-12-10 | 2016-08-10 | Санофі | Протипухлинна комбінація, що містить антитіло, яке специфічно розпізнає cd38, і бортезоміб |
EP2745833A1 (en) * | 2012-12-21 | 2014-06-25 | Institut Gustave Roussy | Soluble, dispersible or orodispersible tablets comprising cyclophosphamide |
WO2016046797A1 (en) | 2014-09-26 | 2016-03-31 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition having improved content uniformity |
SG11201807516UA (en) | 2016-03-17 | 2018-09-27 | Hoffmann La Roche | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
US5110814A (en) * | 1989-01-11 | 1992-05-05 | Asta Pharma Ag | Azelastine and its salts used to combat psoriasis |
DK0468245T3 (da) * | 1990-07-16 | 1994-05-16 | Asta Medica Ag | Tablet og granulat indeholdende mesna som aktivt middel |
UA26305A (uk) * | 1990-07-16 | 1999-08-30 | Аста Медіка Аг | Таблетка, спосіб її одержаhhя, граhулят та спосіб одержаhhя граhулята |
RO113611B1 (ro) * | 1990-08-03 | 1998-09-30 | Asta Pharma Ag | Preparate solide de ifosfamida, administrate oral si procedeu de obtinere |
DE4433764A1 (de) * | 1994-09-22 | 1996-03-28 | Asta Medica Ag | Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit |
AU710490B2 (en) * | 1996-02-22 | 1999-09-23 | Samjin Pharmaceutical Co., Ltd. | New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients |
JPH11322596A (ja) * | 1998-05-12 | 1999-11-24 | Shionogi & Co Ltd | 白金錯体および環状リン酸エステルアミドを含有する抗癌剤 |
US20040034099A1 (en) * | 2002-06-27 | 2004-02-19 | Ramsey Beverly J. | Pharmaceutical composition |
-
1998
- 1998-06-15 DE DE19826517A patent/DE19826517B4/de not_active Expired - Fee Related
-
1999
- 1999-06-08 PL PL99344832A patent/PL193398B1/pl not_active IP Right Cessation
- 1999-06-08 CA CA002333682A patent/CA2333682C/en not_active Expired - Fee Related
- 1999-06-08 NZ NZ508888A patent/NZ508888A/en not_active IP Right Cessation
- 1999-06-08 TR TR2000/03702T patent/TR200003702T2/xx unknown
- 1999-06-08 JP JP2000554378A patent/JP4891478B2/ja not_active Expired - Fee Related
- 1999-06-08 KR KR1020007014142A patent/KR100679872B1/ko not_active IP Right Cessation
- 1999-06-08 DE DE59912829T patent/DE59912829D1/de not_active Expired - Lifetime
- 1999-06-08 WO PCT/EP1999/003920 patent/WO1999065499A1/de active IP Right Grant
- 1999-06-08 IL IL13994499A patent/IL139944A0/xx active IP Right Grant
- 1999-06-08 HU HU0102788A patent/HU226528B1/hu not_active IP Right Cessation
- 1999-06-08 CZ CZ20004489A patent/CZ302157B6/cs not_active IP Right Cessation
- 1999-06-08 AU AU45085/99A patent/AU771284B2/en not_active Ceased
- 1999-06-08 SK SK1858-2000A patent/SK286185B6/sk not_active IP Right Cessation
- 1999-06-08 BR BR9911276-0A patent/BR9911276A/pt not_active Application Discontinuation
- 1999-06-08 AT AT99927902T patent/ATE310523T1/de active
- 1999-06-08 EP EP99927902A patent/EP1089739B1/de not_active Expired - Lifetime
- 1999-06-08 RU RU2001101903/15A patent/RU2236231C2/ru not_active IP Right Cessation
- 1999-06-08 CN CNB998074330A patent/CN1177590C/zh not_active Expired - Fee Related
- 1999-06-08 DK DK99927902T patent/DK1089739T3/da active
- 1999-06-08 ES ES99927902T patent/ES2255276T3/es not_active Expired - Lifetime
- 1999-06-09 TW TW088109644A patent/TWI242450B/zh not_active IP Right Cessation
- 1999-06-10 DE DE29921466U patent/DE29921466U1/de not_active Expired - Lifetime
- 1999-06-11 CO CO99036819A patent/CO5070588A1/es unknown
- 1999-06-15 US US09/333,256 patent/US20010046504A1/en not_active Abandoned
- 1999-06-15 AR ARP990102862A patent/AR019670A1/es not_active Application Discontinuation
- 1999-08-06 UA UA2001010222A patent/UA75566C2/uk unknown
-
2000
- 2000-11-27 IL IL139944A patent/IL139944A/en not_active IP Right Cessation
- 2000-11-28 ZA ZA200006998A patent/ZA200006998B/en unknown
- 2000-12-12 NO NO20006325A patent/NO325154B1/no not_active IP Right Cessation
-
2001
- 2001-01-10 BG BG105139A patent/BG65253B1/bg unknown
- 2001-11-12 HK HK01107939A patent/HK1037959A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2306103A1 (en) | Novel once-a-day controlled release sulfonylurea formulation | |
HK1039070A1 (en) | Pharmaceutical formulation comprising omeprazole | |
NZ238024A (en) | Pharmaceutical compositions comprising a core of diclofenac or piroxicam and a mantle coating of a prostaglandin | |
WO2001037816A3 (en) | Coating of tablet cores | |
MXPA02000277A (es) | Particulas de encubrimiento de textura que contienen un ingrediente activo. | |
IS5404A (is) | Lyfjablanda sem inniheldur klódrónat sem virkt innihaldsefni og síliseraðan örkristallaðan sellulósa sem burðarefni | |
MXPA05003524A (es) | Preparaciones entericas. | |
MXPA03000880A (es) | Sistemas de recubrimiento multicapa formados por una capa base de tipo gel de capa gruesa y por una capa de cubierta de laca de poliuretano, su fabricacion y uso. | |
HUP0102788A2 (hu) | Ciklofoszfamid filmtabletták és eljárás az előállításukra | |
AU6611396A (en) | New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds | |
CA2063141A1 (en) | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets | |
NZ333838A (en) | Polymorph II form of trovafloxcin mesylate, a lubricant, and at least 5% microcrystalline cellulose | |
CA2182939A1 (en) | A rapidly disintegrating medicinal form of tramadol or a tramadol salt | |
CA2340054A1 (en) | Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles | |
GB0113403D0 (en) | Tablet enrobing | |
CA2219308A1 (en) | New process for the preparation of ropivacaine hydrochloride monohydrate | |
AU8104991A (en) | Gelatin coated medicament and process for making same | |
BG104799A (en) | Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings | |
AU4539396A (en) | Fungicidal aza-heterocycloalkenes | |
GEP20094649B (en) | Orodispersible pharmaceutical composition of an antithrombotic compound | |
CA2057456A1 (en) | Anti depression pharmaceutical | |
CA2285852A1 (en) | Pharmaceutical tablet comprising lisinopril disodium and microcrystalline cellulose | |
JP2000235963A5 (hu) | ||
CA2420056A1 (en) | 1-amino-alkylcyclohexanes as trypanocidal agents | |
AU4356299A (en) | Utilization of growth factors for the production of medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: BAXTER HEALTHCARE S. A., CH Free format text: FORMER OWNER(S): ASTA MEDICA AG., DE Owner name: BAXTER INTERNATIONAL INC., US Free format text: FORMER OWNER(S): ASTA MEDICA AG., DE |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |